Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
10/2014
10/09/2014DE102013106462B3 Detektionsverfahren zur Detektion von Bakterien, Verfahren zur Herstellung von Fusionsproteinen und Fusionsprotein Detection methods for the detection of bacteria, processes for the production of fusion proteins and fusion protein
10/08/2014EP2787079A1 IgA-BINDING PEPTIDE AND PURIFICATION OF IgA THEREBY
10/08/2014EP2785838A2 Targeted lysosomal enzyme compounds
10/08/2014EP2785837A2 Targeted enzyme compounds and uses thereof
10/08/2014EP2785744A1 Protein inhibitors to complement and vegf pathways and methods of use thereof
10/08/2014EP2785362A2 Anticancer fusion protein
10/07/2014US8852866 Method for producing and identifying soluble protein domains
10/07/2014US8852612 Universal carrier for targeting molecules to Gb3 receptor expressing cells
10/07/2014US8852604 Multiepitope vaccine for Her2/neu-associated cancers
10/07/2014US8852602 Immunological herpes simplex virus antigens and methods for use thereof
10/02/2014WO2014160508A1 Methods and compositions for treating cancer and inflammatory diseases
10/02/2014WO2014158900A1 Insulin-incretin conjugates
10/02/2014WO2014156958A1 Nano-capsule, composition, polynucleotide, recombinant vector, and transformant
10/02/2014WO2014155356A1 New uranium-chelating peptides derived from ef-hand calcium-binding motif useful for uranium biodetection and biodecontamination
10/02/2014WO2014154187A1 Preparation and use of dimerized fusion protein
10/02/2014WO2014154019A1 Long-lasting immune fusion protein for treating diabetes
10/02/2014US20140296478 Method for selecting a candidate drug compound
10/02/2014US20140294886 Isolated protein and compositions comprising the protein
10/02/2014US20140294885 Heterologous expression of neisserial proteins
10/02/2014US20140294876 Amyloid Beta 1-6 Antigen Arrays
10/01/2014EP2784094A1 New uranium-chelating peptides derived from EF-hand calcium-binding motif useful for uranium biodetection and biodecontamination
10/01/2014EP2784080A1 Peptide-hinge-free flexible antibody-like molecule
09/2014
09/30/2014US8846874 IgG Fc fragment for a drug carrier and method for the preparation thereof
09/30/2014US8846873 Antibodies directed to GPNMB and uses thereof
09/30/2014US8846052 Bacterial toxin vaccine
09/30/2014CA2482597C Compositions and methods for regulation of plant gamma-tocopherol methyltransferase
09/30/2014CA2285426C Detection of molecular interactions by reporter subunit complementation
09/25/2014WO2014152678A1 Compositions and methods for delivering agents to the central nervous system
09/25/2014WO2014149067A1 Methods related to ctla4-fc fusion proteins
09/25/2014WO2014146603A1 Pasteurella multocida toxin recombinant protein and use thereof
09/25/2014US20140287457 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
09/24/2014EP2780376A1 Methods and products for increasing frataxin levels and uses thereof
09/23/2014US8841251 Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors
09/23/2014US8840907 Isolated protein and compositions comprising the protein
09/23/2014CA2658231C Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo
09/23/2014CA2646934C Methods for reducing protein aggregation
09/23/2014CA2548990C Toll-like receptor 4 (tlr4)-neutralizing antibodies
09/18/2014WO2014145964A1 Fusion proteins and methods for stimulating plant growth, protecting plants, and immobilizing bacillus spores on plants
09/18/2014WO2014145174A1 Immunogenic human rhinovirus (hrv) compositions
09/18/2014WO2014145159A2 Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use
09/18/2014WO2014144969A1 Extracellular matrix-binding synthetic peptidoglycans
09/18/2014WO2014144658A1 Dual reactivity potent kunitz inhibitor of fibrinolysis
09/18/2014WO2014142591A1 Protein in which electrical interaction is introduced within hydrophobic interaction site and preparation method therefor
09/18/2014WO2014139994A1 Growth hormone compounds
09/18/2014WO2014138937A1 A growth hormone secretagogue receptor based protein, nucleic acids and methods and uses thereof
09/18/2014WO2014138924A1 Compositions and methods for treating clostridium difficile-associated diseases
09/18/2014US20140275479 Specific binding agents of human angiopoeitin-2
09/18/2014US20140271692 Novel immunogenic epitopes for immunotherapy
09/17/2014EP2776567A2 Compositions and methods for treatment of cytomegalovirus
09/16/2014US8835617 Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same
09/16/2014US8835399 Near-infrared light-activated proteins
09/12/2014WO2014137161A1 Improved preparation method for high-yield production of physiologically active polypeptide conjugate
09/12/2014WO2014136971A1 Method for producing compound containing heterocycle
09/12/2014WO2014136814A1 Novel peptide having 5 linked ctl epitopes
09/11/2014US20140256652 Polypeptides Involved In Immune Response
09/11/2014US20140255410 Specific binding proteins and uses thereof
09/10/2014EP2773674A1 Immunologic constructs and methods
09/10/2014EP2773673A1 Fusion protein comprising c-terminal domain of ret protein and use thereof as a diagnosing marker
09/10/2014EP2773660A2 Chimeric human-camel antigens and their use
09/09/2014US8828928 Amphiphilic peptides and peptide particles
09/09/2014US8828669 Methods of screening for a compound that inhibits the interaction between BAFF and BCMA
09/09/2014US8828407 Chimaeric protein
09/09/2014CA2634760C Compositions and methods for producing a composition
09/09/2014CA2585231C Self-assembling split-fluorescent protein systems
09/09/2014CA2258721C Chimeric heteromultimer adhesins
09/03/2014EP2771367A1 Gigaxonin fusion protein and methods for treating giant axonal neuropathy
09/03/2014EP2771366A1 Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes
09/03/2014EP2771355A1 A MODIFIED EFFECTOR CELL (OR CHIMERIC RECEPTOR) FOR TREATING DISIALOGANGLIOSIDE Gp2-EXPRESSING NEOPLASIA
09/02/2014US8822650 Method for the mass production of immunoglobulin constant region
09/02/2014US8822648 Antibody derivatives
09/02/2014US8822647 Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cells
09/02/2014US8822639 Transferrin fusion protein libraries
09/02/2014US8822636 Peptides for activation and inhibition of δPKC
09/02/2014US8822165 Method for producing cAMP using chimeric olfactory receptor
09/02/2014US8821895 Streptococcus pyogenes antigens and corresponding DNA fragments
09/02/2014US8821883 Method of treating B cell cancers by administering truncated BAFF receptors
09/02/2014CA2594918C Dr5 antibodies and uses thereof
08/2014
08/28/2014WO2014130975A1 Fusion polynucleotides and fusion polypeptides associated with cancer and particularly melanoma and their uses as therapeutic and diagnostic targets
08/28/2014WO2014130723A1 Methods and compositions for treatment of pompe disease
08/28/2014WO2014130722A1 Methods and compositions for treatment of forbes-cori disease
08/28/2014WO2014129876A1 Method of isolating and purifying fusion protein comprising factor vii
08/28/2014WO2014127478A1 Vaccine composition
08/28/2014WO2014106001A3 Dual specific binding proteins having a receptor sequence
08/28/2014US20140242106 Staphylococcus aureus proteins and nucleic acids
08/27/2014EP2768863A1 Anti-cd22 chimeric antigen receptors
08/26/2014US8816057 T1R taste receptors and genes encoding same
08/26/2014US8815550 Targeted perhydrolases
08/26/2014US8815525 Binding and functional assays that use the T1R3 receptor to screen for taste modulatory compounds
08/26/2014US8815517 Methods for identifying functionally related genes and drug targets
08/26/2014US8815238 Methods for Preparing TACI-immunoglobulin fusion proteins
08/26/2014CA2691539C Modified toxins
08/21/2014WO2014127287A1 Method for in vivo tergated mutagenesis
08/21/2014WO2014127191A1 Compositions and methods relating to hindering dot1l recruitment by mll-fusion proteins
08/21/2014WO2014126582A1 IL-1β INHIBITOR COMPOSITION AND USE THEREOF
08/21/2014WO2014124487A1 Ligand binding molecules and uses thereof
08/21/2014US20140234945 Transthyretin variants
08/21/2014US20140234334 Peptides and related molecules that bind to tall-1
08/21/2014US20140234221 Antigen-binding proteins comprising recombinant protein scaffolds
08/20/2014EP2767834A2 Quantitative standard for mass spectrometry of proteins
08/19/2014US8808666 Peptides that specifically target amyloid deposits
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 295